Tracking NIFTY PHARMA - TRI
Less expense ratio implies better returns over the long term
ETF has not been able to closely match its benchmark returns
Good time to consider, as ETF is not in overbought zone
Reliance Nippon Life Asset Management or RNAM is one of India’s two largest asset management companies. Currently, it has over $60 billion in its corpus. It is a wholly owned subsidiary of the Reliance Anil Dhirubhai Ambani or ADA Group.
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro